Patent · US Active

Treating bladder cancer patients and identifying bladder cancer patients responsive to treatment

US9523689B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 21, 2012
Grant dateDec 20, 2016
Priority date
Expiry dateDec 19, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/585
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This documents provided methods and materials involved in treating bladder cancer. This document also provides methods and materials involved in identifying bladder cancer patients likely or unlikely to respond to treatment (e.g., BCG therapy).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.